Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).

As a malignant tumor type, nasopharyngeal carcinoma (NPC) is characterized by distinct geographical, ethnic and genetic differences; presenting a major threat to human health in many countries, especially in Southern China. At present, no accurate and effective methods are available for the early diagnosis, efficacious evaluation or prognosis prediction for NPC. As such, a large number of patients have locoregionally advanced NPC at the time of initial diagnosis. Many patients show toxic reactions to overtreatment and have risks of cancer recurrence and distant metastasis owing to insufficient treatment. To solve these clinical problems, high‑throughput '‑omics' technologies are being used to screen and identify specific molecular biomarkers for NPC. Because of the lack of comprehensive descriptions regarding NPC biomarkers, the present study summarized the research progress that has been made in recent years to discover NPC biomarkers, highlighting the existing problems that require exploration. In view of the lack of authoritative reports at present, study design factors that affect the screening of biomarkers are also discussed here and prospects for future research are proposed to provide references for follow‑up studies of NPC biomarkers.

Citation

Shan-Qiang Zhang, Su-Ming Pan, Si-Xian Liang, Yu-Shuai Han, Hai-Bin Chen, Ji-Cheng Li. Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review). International journal of oncology. 2021 Apr;58(4)

PMID: 33649830

search → result